Pharmacology and efficacy of cyclooxygenase (COX) inhibitors
- 1 December 1999
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 107 (6) , 18-22
- https://doi.org/10.1016/s0002-9343(99)00364-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Differential inhibition of cyclooxygenases-1 and -2 by meloxicam and its 4′-isomerInflammation Research, 1998
- CYCLOOXYGENASES 1 AND 2Annual Review of Pharmacology and Toxicology, 1998
- Differentiating among nonsteroidal antiinflammatory drugsby pharmacokinetic and pharmacodynamic profilesSeminars in Arthritis and Rheumatism, 1997
- Meloxicam: Selective COX-2 inhibition in clinical practiceSeminars in Arthritis and Rheumatism, 1997
- Human whole blood assays for inhibition of prostaglandin G/H synthases-1 and-2 using A23187 and lipopolysaccharide stimulation of thromboxane B2 productionInflammation Research, 1996
- The mode of action of aspirin-like drugs: effect on inducible nitric oxide synthase.Proceedings of the National Academy of Sciences, 1995
- NimesulideDrugs, 1994
- Nonsteroidal Anti-inflammatory Drug Use and Increased Risk for Peptic Ulcer Disease in Elderly PersonsAnnals of Internal Medicine, 1991
- Nonsteroidal Antiinflammatory Drugs and Aspirin—Analyzing the ScoresPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1985
- Antirheumatic Drug Concentrations in Human Synovial Fluid and Synovial TissueClinical Pharmacokinetics, 1983